2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Most viral peptides displayed by class I MHC on infected cells are immunogenic

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          CD8 + T cells are key to the defense of animals against virus infection. These immune cells recognize peptides derived from viral proteins that are displayed on the surface of infected cells in a complex with host proteins known as MHC I. Many viral peptides are displayed by MHC I on infected cells, but it has never been shown what fraction of these can induce an immune response. We answered this long-standing question, finding that more than 80% of vaccinia virus peptides presented by MHC I on infected mouse cells were immunogenic across a population of mice.

          Abstract

          CD8 + T cells are essential effectors in antiviral immunity, recognizing short virus-derived peptides presented by MHC class I (pMHCI) on the surface of infected cells. However, the fraction of viral pMHCI on infected cells that are immunogenic has not been shown for any virus. To approach this fundamental question, we used peptide sequencing by high-resolution mass spectrometry to identify more than 170 vaccinia virus pMHCI presented on infected mouse cells. Next, we screened each peptide for immunogenicity in multiple virus-infected mice, revealing a wide range of immunogenicities. A surprisingly high fraction (>80%) of pMHCI were immunogenic in at least one infected mouse, and nearly 40% were immunogenic across more than half of the mice screened. The high number of peptides found to be immunogenic and the distribution of responses across mice give us insight into the specificity of antiviral CD8 + T cell responses.

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The immune epitope database (IEDB) 3.0

          The IEDB, www.iedb.org, contains information on immune epitopes—the molecular targets of adaptive immune responses—curated from the published literature and submitted by National Institutes of Health funded epitope discovery efforts. From 2004 to 2012 the IEDB curation of journal articles published since 1960 has caught up to the present day, with >95% of relevant published literature manually curated amounting to more than 15 000 journal articles and more than 704 000 experiments to date. The revised curation target since 2012 has been to make recent research findings quickly available in the IEDB and thereby ensure that it continues to be an up-to-date resource. Having gathered a comprehensive dataset in the IEDB, a complete redesign of the query and reporting interface has been performed in the IEDB 3.0 release to improve how end users can access this information in an intuitive and biologically accurate manner. We here present this most recent release of the IEDB and describe the user testing procedures as well as the use of external ontologies that have enabled it.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            NetMHCcons: a consensus method for the major histocompatibility complex class I predictions.

            A key role in cell-mediated immunity is dedicated to the major histocompatibility complex (MHC) molecules that bind peptides for presentation on the cell surface. Several in silico methods capable of predicting peptide binding to MHC class I have been developed. The accuracy of these methods depends on the data available characterizing the binding specificity of the MHC molecules. It has, moreover, been demonstrated that consensus methods defined as combinations of two or more different methods led to improved prediction accuracy. This plethora of methods makes it very difficult for the non-expert user to choose the most suitable method for predicting binding to a given MHC molecule. In this study, we have therefore made an in-depth analysis of combinations of three state-of-the-art MHC-peptide binding prediction methods (NetMHC, NetMHCpan and PickPocket). We demonstrate that a simple combination of NetMHC and NetMHCpan gives the highest performance when the allele in question is included in the training and is characterized by at least 50 data points with at least ten binders. Otherwise, NetMHCpan is the best predictor. When an allele has not been characterized, the performance depends on the distance to the training data. NetMHCpan has the highest performance when close neighbours are present in the training set, while the combination of NetMHCpan and PickPocket outperforms either of the two methods for alleles with more remote neighbours. The final method, NetMHCcons, is publicly available at www.cbs.dtu.dk/services/NetMHCcons , and allows the user in an automatic manner to obtain the most accurate predictions for any given MHC molecule.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules.

              Pathways for presenting proteins from the extracellular fluids on MHC class I molecules have been described in macrophages. However, it is uncertain whether similar mechanisms exist in dendritic cells, because conventional preparations of these cells can be contaminated with macrophages. We addressed this issue by transducing granulocyte-macrophage CSF into bone marrow cultures followed by supertransfection with myc and raf oncogenes. These immortalized clones displayed dendritic morphology, and many expressed the dendritic cell-specific markers DEC-205 and 33D1 as well as high levels of MHC molecules and costimulatory molecules. Using these cloned dendritic cells, we found that exogenous OVA could be presented on both their MHC class I and class II molecules. This presentation was markedly enhanced when the Ag was particulate and internalized by phagocytosis. Presentation of particulate OVA on MHC class I molecules was insensitive to the weak base chloroquine, but was blocked by peptide aldehyde inhibitors of the proteasome, indicating that the class I-presented peptides were generated in the cytosol. Brefeldin A, which inhibits the exocytosis of newly synthesized proteins from the endoplasmic reticulum, also inhibited Ag presentation. These results establish that dendritic cells can present exogenous Ags on MHC class I molecules and appear to use a similar phagosome to cytosol pathway as macrophages. Therefore, dendritic cells are likely to play an important role in generating immune responses to tissue transplants and tumors in vivo. Furthermore, these findings provide an approach for targeting vaccine Ags into these cells to prime immune responses in vivo.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                19 February 2019
                4 February 2019
                4 February 2019
                : 116
                : 8
                : 3112-3117
                Affiliations
                [1] aInfection and Immunity Program, Biomedicine Discovery Institute, Monash University , Clayton, VIC 3800, Australia;
                [2] bDepartment of Biochemistry and Molecular Biology, Monash University , Clayton, VIC 3800, Australia;
                [3] cJohn Curtin School of Medical Research, The Australian National University , Canberra, ACT 2601, Australia;
                [4] dDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology , La Jolla, CA 92037;
                [5] eDepartment of Medicine, University of California, San Diego , La Jolla, CA 92093;
                [6] fDepartment of Microbiology and Immunology, University of Melbourne , The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia
                Author notes

                Edited by Emil R. Unanue, Washington University, St. Louis, MO, and approved January 4, 2019 (received for review September 4, 2018)

                Author contributions: N.P.C., N.L.L.G., A.W.P., and D.C.T. designed research; N.P.C., S.A.S., J.P., J.S., M.J.W., P.S., I.E.A.F., and S.L.H. performed research; N.P.C., J.S., B.P., P.F., and D.C.T. analyzed data; and N.P.C., J.S., B.P., P.F., A.S., N.L.L.G., A.W.P., and D.C.T. wrote the paper.

                2A.W.P. and D.C.T. contributed equally to this work.

                Author information
                http://orcid.org/0000-0002-2128-5127
                http://orcid.org/0000-0003-0532-8331
                http://orcid.org/0000-0001-6825-9172
                Article
                201815239
                10.1073/pnas.1815239116
                6386720
                30718433
                8ba311a1-7c83-4905-b176-40e419b92649
                Copyright © 2019 the Author(s). Published by PNAS.

                This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND).

                History
                Page count
                Pages: 6
                Funding
                Funded by: Department of Health | National Health and Medical Research Council (NHMRC) 501100000925
                Award ID: APP1084283
                Award Recipient : Nathan P Croft Award Recipient : Nicole L La Gruta Award Recipient : Anthony W Purcell Award Recipient : David C. Tscharke
                Funded by: Department of Health | National Health and Medical Research Council (NHMRC) 501100000925
                Award ID: APP1104329
                Award Recipient : Nathan P Croft Award Recipient : Nicole L La Gruta Award Recipient : Anthony W Purcell Award Recipient : David C. Tscharke
                Funded by: Department of Health | National Health and Medical Research Council (NHMRC) 501100000925
                Award ID: APP1137739
                Award Recipient : Nathan P Croft Award Recipient : Nicole L La Gruta Award Recipient : Anthony W Purcell Award Recipient : David C. Tscharke
                Funded by: Department of Health | National Health and Medical Research Council (NHMRC) 501100000925
                Award ID: APP1071916
                Award Recipient : Nathan P Croft Award Recipient : Nicole L La Gruta Award Recipient : Anthony W Purcell Award Recipient : David C. Tscharke
                Categories
                Biological Sciences
                Immunology and Inflammation

                antigen presentation,virus,cd8+ t cells,mhc class i,vaccinia virus

                Comments

                Comment on this article